MARKSANS NSE filing

Marksans Pharma to Participate in Ashwamedh - Elara India Dialogue 2026 on Sep 2nd

The RealCase readLow impact Neutral

Marksans Pharma Limited will attend the Ashwamedh - Elara India Dialogue 2026 on September 2nd, 2026. The physical meet will be held in Mumbai. No price-sensitive information will be shared.

Why it matters

Participation in an investor meet is a standard corporate activity and is unlikely to have a significant immediate impact on the company's stock price or business operations.

The market read

The announcement is a routine intimation of participation in an investor event and does not contain any material financial or operational updates that would influence sentiment.

Marksans Pharma Limited has announced its participation in the Ashwamedh - Elara India Dialogue 2026. The event is scheduled to take place on 02nd September, 2026, and will be held in a physical mode at Hyatt, Santacruz East, Mumbai.

This engagement is part of the company's ongoing efforts to connect with investors and analysts. Marksans Pharma has clarified that no unpublished price-sensitive information will be disclosed during the meet. The schedule is subject to change based on unforeseen circumstances affecting either the company or the participating investors/analysts.

Further details and updates regarding this event will be available on the company's official website, www.marksanspharma.com.

Primary source

A plain-language summary of a public exchange filing by Marksans Pharma Limited. Read the original for the full detail.

View original filing
This is RealCase

Every move, explained.

Expert model portfolios with exact weights, an Active or Hold state on every holding, and a written reason behind every change. In your pocket.

Coming soon toApp StoreComing soon toGoogle Play
100% digital · your money stays in your own broker · your data is secure
RealCase
Your RealCases
Core Compounders
Stocks
13.4%
Flexi Core
Mutual Funds
13.1%
Latest change
ActiveHDFC Bank10% → 14%

“Deposits growing faster than loans again. We add on strength, funded from cash.”

₹0Commission · fee-only